MAGEA4 and breast carcinoma: In comparison, 65% of the cases (53/81) studied by Bandic et al. were ER-negative tumors, and this would at least partially account for the higher expression of NY-ESO-1 and MAGE-A4 proteins in their series of recurrent breast cancer.